TXNDC5 and prostate cancer: Aberrant TXNDC5 expression has been reported in multiple malignancies, and is involved in the modulation of tumor cell cycle, proliferation, and migration, likely representing an important event in the progression of cervical cancer, prostate cancer, and lung cancer [18, 19, 29].